partially inhibited T lymphocyte adhesion to intact fibronectin. However, inhibition of T lymphocyte or RD cell adhesion to fibronectin was most efficient when the inhibitory antibodies to ?4/?1 and ?5/?1 were used together.
| Inventor | Institute |
|---|---|
| Elizabeth A. Wayner | Fred Hutchinson Cancer Center |
| Cat. #: | 161660 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Cell biology |
| Application: | FACS, Function Blocking, Immunofluorescence, Immunohistochemistry, Immunoprecipitation |
| Target: | Integrin alpha-4 (CD49d) |
| Reactivity: | Human |
| Clone: | P4G9 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Wayner et al. 1989. Journal of Cell Biology. 109(3):1321-30. PMID: 2527858 |
| Product description: | MoAb P4G9 was developed to identify a new fibronectin receptor that is identical to the integrin receptor ?4/?1. P4G9 recognized epitopes on the ?4 subunit and completely inhibited the adhesion of peripheral blood and cultured T lymphocytes to a 38-kD tryptic fragment of plasma fibronectin containing the carboxy-terminal Heparin II domain and part of the type III connecting segment . The ligand in type III connecting segment (IIICS ) for ?4/?1was the CS-1 region previously defined as an adhesion site for melanoma cells. P4G9 stimulates aggregation of T cells as well. |
|---|---|
| Isotype: | IgG2b |
| Molecular weight: | 114.9 kDa |
| Immunogen: | HT1080 human fibrosarcoma cell line |
| Target background: | A fibronectin receptor that is identical to the integrin receptor ?4?1. CD49 antigen-like family member D, Integrin alpha-IV, VLA-4 subunit ? |
|---|
| Storage conditions: | For immediate use, short term storage at 4°C up to two weeks is recommended. For long term storage, divide the solution into volumes of no less than 20 ul for freezing at -20°C or -80°C. The small volume aliquot should provide sufficient reagent for short term use. Freeze-thaw cycles should be avoided. For concentrate or bioreactor products, an equal volume of glycerol, a cryoprotectant, may be added prior to freezing. |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Wayner et al. 1989. Journal of Cell Biology. 109(3):1321-30. PMID: 2527858 Schiffer et al.1995.J Biol Chem. 270(24):14270-3.PMID: 7782282 Symington et al. 1993.J Cell Biol.120(2):523-35.PMID: 8421064 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.